Orexigen Therapeutics, Inc. Reports Business And Financial Results For The Third Quarter Ended September 30, 2013

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

SAN DIEGO, Nov. 12, 2013 /PRNewswire/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced business and financial results for the third quarter ended September 30, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news